Purchase Order 75N93024P00543
Award Date 4/16/24
Potential Completion Date 6/12/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15,434.00 firm-fixed-price purchase order to Bioreliance Corporation, a foreign-owned for-profit organization, for endotoxin and sterility testing services. The contract has an ultimate completion date of September 8, 2025. Bioreliance, through its Life Sciences Services division, provides specialized microbiological examination, bioburden...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,561.00 firm fixed price purchase order contract to Bioreliance Corporation, a foreign-owned for-profit company, to provide endotoxin, sterility, and general safety testing services in support of investigational new drug applications. The contract includes isolator sterility testing using direct inoculation methods, LAL testing for...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Bioreliance Corporation for endotoxin and sterility testing services. The $16,051.00 firm fixed price contract does not have a set-aside designation, indicating Bioreliance's competitive standing in the field of pharmaceutical and biotechnology research and development. As a foreign-owned, for-profit organization,...
- Bioreliance Corporation, a foreign-owned for-profit organization, was awarded a $34,978 firm-fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) to provide endotoxin, sterility, and general safety testing services in support of investigational new drug (IND) applications for NIAID's Pfs230D1-CRM197 and Pfs230D1-EPA malaria vaccine products. The contract, which does not have a set-aside designation, runs through August 31, 2024. Bioreliance has...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a purchase order to Bioreliance Corporation's Life Sciences Services Division for $237,266.00 to provide laboratory services, including sterility testing. This firm fixed price contract has a completion date of September 18, 2023. Bioreliance, a foreign-owned for-profit organization, will provide sterility testing using direct inoculation methods, Limulus Amebocyte Lysate (LAL) testing...
- This federal contract award, with ID HHSN272201600262P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Bioreliance Corporation, a foreign-owned, for-profit organization that specializes in providing critical testing services to the U.S. government. The $9,566.00 fixed-price contract is for endotoxin testing services, which are crucial for advancing health initiatives and drug development processes. Bioreliance, through its Life Sciences Services Division,...
- The Department of Health and Human Services National Institutes of Health (NIH) National Cancer Institute awarded a $80,848.00 Delivery Order contract to Bioreliance Corporation, a foreign-owned for-profit organization, for sterility testing services. The contract is for endotoxin, sterility, and general safety testing to support investigational new drug applications. Bioreliance has a history of providing these types of testing services to the NIH National Institute of Allergy and Infectious...
- This contract award is for the delivery of sterility units, catalog number 510011.BSV, to the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The prime contractor is Bioreliance Corporation, a foreign-owned for-profit organization that provides endotoxin, sterility, and general safety testing services through its Life Sciences Services division. The contract is a firm fixed-price delivery order with a potential value of $35,018.20...
- This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization that provides endotoxin, sterility, and general safety testing services through its Life Sciences Services division. The contract is for the delivery of Sterility Units, catalog number 510120GMP.BSV, with a firm fixed price of $35,018.20 and a completion date of June 30, 2013. No...
- This is a Firm Fixed Price Delivery Order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bioreliance Corporation, a foreign-owned for-profit organization. The contract, valued at $87,849.55, is for sterility testing services (STERILITY (510120GMP.BSV)) with a completion date of November 20, 2014. Bioreliance, through its Life Sciences Services Division, is a specialized provider of microbiological examination,...